Skip to main content

Effects of Nutritional Treatment on Hormonal and Metabolic Derangements of the Uremic Syndrome

  • Chapter
Nutritional Treatment of Chronic Renal Failure

Part of the book series: Topics in Renal Medicine ((TIRM,volume 7))

Abstract

Secondary hyperparathyroidism (HPTH) is common in patients with CRF and is constant in severe cases. A conventional low-nitrogen diet (CLND) (0.6 g/kg/day) can prevent HPTH only in early renal failure [1–2], but a very-low-phosphorus, low-PR vegan diet supplemented with CaCO3 and a mixture of essential amino acids (EAAs) and calcium salts of keto analogues (KAs) can reverse secondary HPTH, even in severe cases (figure 27–1) [3–6]. The fall of serum inorganic phosphorus (sPi) (causing an increase of ionized calcium) and an increase of total serum calcium are the most probable causes of the reversal of secondary HPTH, which is accompanied by a fall in serum alkaline phosphatase. This is known to indicate an improvement of uremic osteodystrophy [7]. It has been reported, however, that a mixture of EAAs and KAs can lower serum parathyroid hormone (PTH), even in chronic uremics on maintenance hemodialysis (MHD) and free diet [8], suggesting that the EAAs and KAs supplement acts directly, or through its calcium content, on PTH secretion. Dietary phosphorus restriction facilitates intestinal calcium absorption and also raises 1,25(OH)2D3 levels [9] but this is unlikely to occur in uremic patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Llach F, Massry SG, Koffler A, Malluche HM, Singer FR, Brickman AS, Kurokawa K: (1977) Secondary hyperparathyroidism (200B0 HPTISM) in early renal failure (ERN): Role of phosphate (P) retention (abstr). Clin Res 25:507.

    Google Scholar 

  2. Maschio G, Tessitore N, Bonucci E, D’Angelo A, Fiaschi E: (1979) Early dietary phosphorus restriction and calcium supplementation in prevention of renal osteodystrophy. Abstract Book, 2nd Int Congr Nutr in Renal Disease, Bologna, 1979, pp 93.

    Google Scholar 

  3. Barsotti G, Morelli E, Guiducci A, Ciardella F, Giannoni A, Lupetti S, Giovannetti S: (1982) Reversal of hyperparathyroidism in severe uremics following very low-protein and low-phosphorus diet. Nephron 30:310–313.

    Article  PubMed  CAS  Google Scholar 

  4. Froehling PT, Kokot F, Schmicker R, Kaschube I, Lindenau K, Vetter K: (1984) Influence of keto acids on serum parathyroid hormone levels in patients with chronic renal failure. Clin Nephrol 20:212–215.

    Google Scholar 

  5. Froehling PT, Schmicker R, Vetter K, Kaschube I, Goetz KH, Jacopian M, Klinkman H: (1980) Conservatve treatment with keto acid and amino supplemented low protein diets in chronic renal failure. Am J Clin Nutr 33:1667–1672.

    Google Scholar 

  6. Barsotti G, Ciardella F, Morelli E, Guiducci A, Cecchettin M, Giovannetti S: (1981) Circulating PTH levels in patients following a very low protein diet supplemented with essential amino acids and keto analogues. VIIIth Int Congr Nephrology, Athens, 1981, pp 283.

    Google Scholar 

  7. Massry SG, Goldstein DA, Malluche HH: (1980) Current status of the use of 1,25(OH)2D3 in the management of renal osteodystrophy. Kidney Int 18:409–418.

    Article  PubMed  CAS  Google Scholar 

  8. Lindenau K, Kokot F, Froehling PT: (1986) Suppression of parathyroid hormone by therapy with a mixture of keto analogues/amino acids in hemodialysis patients. Nephron 43:84–86.

    Article  PubMed  CAS  Google Scholar 

  9. Lucas PA, Brown RC, Woodhead JS, Coles GA: (1986) 1,25-dihydroxycholecalciferol and parathyroid hormone in advanced chronic renal failure: Effects of simultaneous protein and phosphorus restriction. Clin Nephrol 23:7–10.

    Google Scholar 

  10. Fioretti P, Melis GB, Ciardella F, Barsotti G, Orlandi MC, Paoletti AM, Giovannetti S: (1986) Parathyroid function and pituitarygonadal axis in male uremics; effects of dietary treatment and of maintenance hemodialysis. Clin Nephrol 25:155–158.

    PubMed  CAS  Google Scholar 

  11. Massry SG, Goldstein DA: (1978) Role of parathyroid hormone in uremic toxicity. Kidney Int 13:39–41.

    Google Scholar 

  12. Massry SG: (1985) Current status of the role of parathyroid hormone in uremic toxicity. Contr Nephrol 49:1–11.

    CAS  Google Scholar 

  13. Barsotti G, Ciardella F, Morelli E, Fioretti P, Melis GB, Paoletti AM, Niosi F, Caprioli R, Fosso A, Carbone C, Giovannetti S: (1985) Restoration of blood levels of testosterone in male uremics following a low protein diet supplemented with essential amino acids and ketoana-logues. Clin Nephrol 49:63–69.

    CAS  Google Scholar 

  14. Froehling PT, Birnbaum, M, Halle H, Lindenau K: (1986) Successful pregnancy of a woman with advanced renal failure on nutritional treatment. Nephron 44:195–197.

    Article  Google Scholar 

  15. Mooradian AD, Morley JE: (1984) Endocrine dysfunction in chronic renal failure. Arch Intern Med 144:351–353.

    Article  PubMed  CAS  Google Scholar 

  16. Peces R, Horcajada C, Lopez-Novoa JM, Frutos MA, Casados S, Hernando L: (1981) Hyper-prolactinemia in chronic renal failure. Impaired responsiveness to stimulation and suppression. Normalization after transplantation. Nephron 28:11–16.

    Article  PubMed  CAS  Google Scholar 

  17. Ciardella F, Melis GB, Barsotti G, Morelli E, Baoletti, AM, Beneventi F: (1983) Prolactin secretion in patients with chronic renal failure (CRF) treated with hemodialysis (HD) or very low protein diet (VLPD). Intern Symp. Therapy of Reproductive Disorders with Dopaminergic Drugs. Viareggio (Italy), 1983, Abstract Book, p 45.

    Google Scholar 

  18. Davis FB, Spector DA, Davis PJ, Hirsch BR, Walshe JJ, Yoshida. K: (1982) Comparison of pituitary-thyroid function in patients with end stage renal disease and in age and sex matched controls. Kidney Int 21:362–364.

    Article  PubMed  CAS  Google Scholar 

  19. Kaptein EM, Feinstein EI, Nassty SG: (1982). Thyroid hormone metabolism in renal disease. Contr Nephrol 33:122–135.

    CAS  Google Scholar 

  20. Jackson IM: (1982) Thyrotropin-releasing-hormone. N Engl J Med 306:145–155.

    Article  PubMed  CAS  Google Scholar 

  21. Ciardella F, Morelli E, Caprioli R, Casto G, Christu C, Rampa P, Petronio MG, Carbone C, Mantovanelli A, Mazzotta L, Barsotti G: (1986) Restoration of thyroid secretion in uremic patients following a low protein low phosphorus diet supplemented with essential amino acids and keto analogues. Contr Nephrol 53:51–57.

    CAS  Google Scholar 

  22. Barsotti G, Ciardella F, Carpi A, Niccolini A, Caprioli R, Carbone C, Cupisti A, Bianchi R, Giovannetti S: (1985) Effects of a low protein diet supplemented with aminoacids and keto-analogues (SD) on thyroid hormones and pituitary TSH. Fourth Inter Cong on Nutrition and Metabolism in Renal Disease, Williamsburg, Virginia (USA), October 10–13, 1985, Abstract Book.

    Google Scholar 

  23. Ciardella F, Carpi A, Caprioli R, Niccolini A, Morelli E, Iervasi G, Bianchi R, Barsotti G: (1985) Thyroid function in chronic renal failure (CRF): Effects of a low protein diet supplemented with essential aminoacids and ketoanalogues (SD). Inter Meeting: Thyroid Function and Dysfunction: Modern Concepts. Pisa, Oct. 1985, Abstract Book, p 33.

    Google Scholar 

  24. Giovannetti S: (1985) Dietary treatment of chronic renal failure: Why is it not used more frequently? Nephron 40:1–12.

    Article  PubMed  CAS  Google Scholar 

  25. Kaptein EM, Feinstein EI, Massry SG: (1982) Thyroid hormone metabolism in renal diseases. Contr Nephrol 33:122–135.

    CAS  Google Scholar 

  26. Kaptein EM, Quion Verde H, Massry SG: (1984) Hemodynamic effects of thyroid hormone. Contr Nephrol 41:151–159.

    CAS  Google Scholar 

  27. Lai KN, Ng J, Whitford J, Buttfield I, Fassett RG, Methew TH: (1985) Left ventricular function in uremia: Echocardiographic and radionuclide assessment in patients on maintenance hemodialysis. Clin Nephrol 23:125–133.

    PubMed  CAS  Google Scholar 

  28. Gafter U, Battler A, Eldar M, Zevin D, Neufeld HN, Levi J: (1985) Effect of hyperparathyroidism on cardiac function in patients with end-stage renal disease. Nephron 41:30–33.

    Article  PubMed  CAS  Google Scholar 

  29. Prosser D, Parson V: (1975) The case for a specific uraemic myocardiopathy. Nephron 15:4–7.

    Article  PubMed  CAS  Google Scholar 

  30. Rao MB, Bay WH, George JM, Hebert LA: (1986) Primary hypothyroidism in chronic renal failure. Clin Nephrol 25:11–14.

    PubMed  CAS  Google Scholar 

  31. Aronin N, Krieger DT: (1983) Plasma immunoreactive beta-endorphin is elevated in uraemia. Clin Endocrinol 18:459–464.

    Article  CAS  Google Scholar 

  32. Aronin N, Liotta AS, Shickmanter B, Schussler GC, Krieger DT: (1981) Impaired clearance of beta-lipotropin in uremia. J Clin Endocr Metab 53:797–800.

    Article  PubMed  CAS  Google Scholar 

  33. Smith R, Grossman A, Gaillard R, Clement-Jones V, Ratter S, Mallison J, Lowry PJ, Besser GM, Rees LH: (1981) Studies on circulating met-enkephalin and beta-endorphin: Normal subjects and patients with renal and adrenal disease. Clin Endocrinol 15:291–300.

    Article  CAS  Google Scholar 

  34. Rosenblatt M: (1987) The endogenous opiate peptides. In: Braunwald E, Isselbacher KJ, Petersdorf, RG, Wilson JD, Martin JB, Fauci AS (eds) Harrison’s Principles of Internal Medicine 11th edition. New York: McGraw Hill pp 378–382.

    Google Scholar 

  35. Grzeszczak-W, Kokot F, Dulawa J: (1987) Effects of naloxone administration on endocrine abnormalities in chronic renal failure. Am J Nephrol 7:93–100.

    Article  PubMed  CAS  Google Scholar 

  36. Zoccali C, Ciccarelli M, Mallamaci F, Maggiore Q: (1986) Enkephalins in plasma of patients with chronic renal failure. XXIIIrd EDTA-ERA Congress, Budapest, 1986, Abstract Book.

    Google Scholar 

  37. Elias AN, Vaziri ND, Maksy M: (1986) Plasma beta-endorphin and beta-lipotropin in patients with end-stage renal disease. Effects of hemodialysis. Nephron 43:173–176.

    Article  PubMed  CAS  Google Scholar 

  38. Aparicio M, Bouchet JL, Gin H, Potaux L, Morel D, De Precigout V: (1987) Effect of a low protein diet supplemented with essential aminoacids and ketoanalogues (SD) on triglyceride-mia and carbohydrate metabolism in uremia. Xth Intern Congress of Nephrology, London, 1987, Abstract Book, p 496.

    Google Scholar 

  39. De Marchi S, Cecchin E, Villatta D, Tesio F: (1987) Serum reverse T3 assay for predicting glucose intolerance in uremic patients on dialysis therapy. Clin Nephrol 4:189–198.

    Google Scholar 

  40. Snyder D, Pulido LB, Kagan A: (1968) Dietary reversal of the carbohydrate intolerance in uremia. EDTA 5:205–212.

    Google Scholar 

  41. Burman KD, Smallridge RC, Jones L, Ramos EA, O’Brian OT, Wright SD, Wartofsky L: (1980) Glucagon kinetics in fasting: Physiological elevation in serum 3,5,3′ triiodiothyronine increases the metabolic clearance rate of glucagon. J Clin Endocrinol Metab 51:1158–1165.

    Article  PubMed  CAS  Google Scholar 

  42. Massry SG: (1986) Uremia, parathyroid hormone and carbohydrate intolerance. Contr Nephrol 50:96–108.

    CAS  Google Scholar 

  43. Cappelli P, Del Rosso G, Di Paolo B, Evangelista M, Nisi MT, Albertazzi A: (1985) Glucagon-mediated modifications of glomerular filtration rate induced by essential aminoacids and ketoanalogues. Proc EDTA-ERA 22:917–920.

    Google Scholar 

  44. Pfeiffer A, Braun S, Mann K, Meyer HD, Brand V: (1986) Anterior pituitary hormone response to a k-opioid agonist in man. J Clin Endocrinol Metab 62:181–185.

    Article  PubMed  CAS  Google Scholar 

  45. Balestri PL, Rindi P, Biagini M, Giovannetti S: (1972). Effect of uraemic serum, urea, creatinine and methylguanidine on glucose metabolism. Clin Sci 42:395–404.

    PubMed  CAS  Google Scholar 

  46. Balestri PL, Biagini M, Rindi P, Giovannetti S: (1970) Uremic toxins. Arch Intern Med 126: 843–845.

    Article  PubMed  CAS  Google Scholar 

  47. Ciardella F, Morelli E, Caprioli R, Baldi R, Cupisti A, Petronio MG, Carbone C, Barsotti G:(1986) Effects of a low phosphorus, low nitrogen diet supplemented with essential amino acids and ketoanalogues on serum triglycerides of chronic uremic patients. Nephron 42: 196–199.

    Article  PubMed  Google Scholar 

  48. Aparicio M, Potaux L, De Precigout V, Lafage MH, Gin H, Bouchet JL, Martin Dupont PH: (1987) Hypertriglyceridemia and low-phosphorus, low-nitrogen diet in patients with chronic renal failure. Nephron 46:335–336.

    Article  PubMed  CAS  Google Scholar 

  49. Barsotti G, Cupisti A, Caprioli R, Morelli E, Gambelli P, Mantovanelli A, Petronio MG, Fiaschi AR, Ciardella F: (1987) Improvement of uremic hyperlipidemia and endocrinopathies by a low protein diet supplemented with essential aminoacids and ketoanalogues (SD). Xth International Congress of Nephrology. London, July 1987, Abstract Book, p 495.

    Google Scholar 

  50. Barsotti G, Ciardella F, Cupisti A, Morelli E, Mazzotta L, Fosso A, Giovannetti S: (1986) Changes of serum lipids in chronic uremics following a low protein diet supplemented with aminoacids and ketoanalogues (SD). XXIIIrd EDTA-ERA Congress, Budapest 1986, Abstract Book.

    Google Scholar 

  51. Barsotti G, Ciardella F, Morelli E; Bianchi F, Niosi F, Cupisti A, Caprioli R, Giovannetti S: (1985) Effect of a low-nitrogen diet supplemented with essential aminoacids and ketoacids (artificial diet [AD]) on lipid metabolism in uremia. Kidney Int 28:281.

    Google Scholar 

  52. Muls E, Rosseneu M, Lamberigts G, De Moor P: (1985) Changes in the distribution and composition of high density lipoproteins in primary hypothyroidism. Metabolism 34:345–353.

    Article  PubMed  CAS  Google Scholar 

  53. Agdeppa D, Macaron C, Mallik T, Schnuda ND: (1979) Plasma high density lipoprotein cholesterol in thyroid disease. J Clin Endocrinol Metab 49:726–729.

    Article  PubMed  CAS  Google Scholar 

  54. Muls E, Rosseneu M, Bury J, Stul M, Lamberigts G, De Moor P: (1985) Hyperthyroidism influences the distribution and apolipoprotein-A composition of the high density lipoproteins in man. J Clin Endocrinol Metab 61:882–889.

    Article  PubMed  CAS  Google Scholar 

  55. Gutai J, Laporte D, Kuller L, Dai W, Falvo-Gerard L, Caggiula A: (1981) Plasma testosterone, high density lipoprotein cholesterol and other lipoprotein fractions. Am J Card 48:897–902.

    Article  PubMed  CAS  Google Scholar 

  56. Kasiske BL, O’Donnell MP, Garvis WJ, Keane WF: (1987) Cholesterol synthesis inhibition reduces glomerular injury in the rat 5/6 nephrectomy model of chronic renal failure. Xth International Congress of Nephrology, London July 1987, Abstract Book, p 504.

    Google Scholar 

  57. Moorhead JF, Chan MK, Varghese Z: (1986) The role of abnormalities of lipid metabolism in the progression of renal disease. In: Mitch WE, Brenner BM, Stein JH (eds) Contemporary Issues in Nephrology: The progressive Nature of Renal Disease, Vol 14, New York: Churchill Livingstone, pp 133–148.

    Google Scholar 

  58. Lucas PA, Meadows JH, Roberts DE, Cloes GA: (1986) The risks and benefits of a low protein-essential amino acid-keto acid diet. Kidney Int 29:995–1003.

    Article  PubMed  CAS  Google Scholar 

  59. El Nahas AM, Coles GA: (1986) Dietary treatment of chronic renal failure: Ten unanswered questions. Lancet:597–600.

    Google Scholar 

  60. Ciardella F, Cupisti A, Morelli E, Niosi F, Fosso A, Rampa P, Barsotti G: (1986) Improvement of nutritional status in chronic uremics following a low protein diet supplemented with essential aminoacids and ketoanalogues (SD). XXIII EDTA-ERA Congr Budapest, Abstract Book.

    Google Scholar 

  61. Di Landro D, Bertoli M, Ruffatti A, Gasparetto ML, Naso A, Perin N, Franco GC, Romagnoli GF: (1982) Role of low protein diet, essential amino acids and keto analogues in uremia. IIIrd Intern Congress on Nutrition and Metabolism in Renal Disease, Marseille, 1982, Abstract Book.

    Google Scholar 

  62. Romagnoli GF, Ruffatti A, Bertoli M, Gasparotto M, Naso A, Perin N, Lagomansini P, Camilotto R, Rebeschini M, Favaro P, DiLandro D: (1983) Role of low protein diet, essential amino acids and ketoanalogues in uremia. IInd Asian Pacific Congress of Nephrology, Melbourne, 1983, Abstract Book p 67.

    Google Scholar 

  63. Di Landro D, Bisi M, Ruffatti A, Romagnoli GF: (1986) Use of a low protein diet (LPD) essential amino acids (EAA) and keto analogues (KA) in uremic patients. XXIIIrd EDTA-ERA Congress Budapest, 1986, Abstract Book.

    Google Scholar 

  64. Barsotti G, Moriconi L, Cupisti A, Dani L, Ciardella F, Lupetti S, Giovannetti S: Protection of renal function and of nutritional status in uremic rats by means by a low-protein, low-phosphorus supplemented diet. (1988) Nephron 49:197–202.

    Article  PubMed  Google Scholar 

  65. Mariani G, Barsotti G, Ciardella F, Molea N, Morelli E, Mazzuca N, Niosi F, Buonaguidi F, Fusani L, Panicucci F, Giovannett S, Bianchi R: (1984) Albumin metabolism and nutritional status of uremic patients on a long-term very-low-protein diet supplement with essential amino acids and keto analogues. J Nucl Med All Sci 28:237–244.

    CAS  Google Scholar 

  66. Mariani G, Molea N, Barsotti G, Ciardella F, Mazzuca N, Fusani L, Bonaguidi F, Giovanetti S, Bianchi R: (1983) Measurement of albumin turnover and distribution in chronic uremic patients on a long-term very-low-protein diet supplemented with essential aminoacids and keto analogues. In Reynaud C (ed) Nuclear Medicine and Biology. New York: Pergamon Press, pp 569–572.

    Google Scholar 

  67. Verger MF, Verger C, Hall-Magnien D, Perrone F: (1987) Relationship between thyroid hormones and nutrition in chronic renal failure. Nephron 45:211–215.

    Article  PubMed  CAS  Google Scholar 

  68. Mitch WE, Walser M, Sapir D: (1981) Nitrogen sparing induced by leucine compared with that induced by its ketoanalogue alpha-keto-isocaproate in fasting obese men. J Clin Invest 67: 553–562.

    Article  PubMed  CAS  Google Scholar 

  69. Abumrad NN, Cersosimo E, Lacy WW: (1984) Physiologic role of branched chain amino and keto acids in vivo. In: Adibi SA, Fekl W, Langebeck U, Schauder P (eds) Branched Chain Amino and Keto Acids in Health and Disease. Basel: Karger, pp 162–181.

    Google Scholar 

  70. Sapir DG, Stewart PM, Walser m, Moreadith C, Moyer ED, Imbembo AL, Rosenshein NB, Munozz S: (1983) Effects of alpha-ketoisocaproate and of leucine on nitrogen metabolism in postoperative patients. Lancet 7:1010–1013.

    Article  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Kluwer Academic Publishers, Boston

About this chapter

Cite this chapter

Ciardella, F. (1989). Effects of Nutritional Treatment on Hormonal and Metabolic Derangements of the Uremic Syndrome. In: Giovannetti, S. (eds) Nutritional Treatment of Chronic Renal Failure. Topics in Renal Medicine, vol 7. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1583-4_27

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-1583-4_27

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-8877-0

  • Online ISBN: 978-1-4613-1583-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics